Neisseria meningitidis
Major achievements include development of CRM197 used in "Haemophilus influenzae", "Neisseria meningitidis", and "pneumococcus" vaccines; an acellular pertussis vaccine containing a genetically detoxified pertussis toxin; the first conjugate vaccines against meningococcus; MF59 adjuvant for influenza; the meningococcus B genome-derived vaccine.